Ukubukeka kunye nezinye ezininzi i-eye-counter-counter-counter-(counter-counter-counter-counter) (i-OTC). Amaninzi e-OTC amaconsi anama-decongestants angama-topicalist, afana ne-naphazoline kunye ne-tetrahydrozoline, eyenza ukunciphisa ubomvu bamehlo. Olunye isohlo lwe-OTC lusehla ludibanisa ama-decongestants kunye nama-anti-anti -istamines, afunyenwe kwi-Visine-A ne-Opcon-A.
Nangona la manzi ahlukeneyo iliso lisebenza ngokukhawuleza kwexesha elifutshane lokukhululeka kwamehlo obomvu, kunye nokukhangela kwamehlo xa i- anti - stistamine ye- topical ishicilelwe , ukusetyenziswa kwexesha elide lamagosa angama-decongestants angakhokelela kwimiphumo emibi.
Ukuxhomekeka kwiNtsontsho Yamehlo
Xa iliso le-decongestant eye lihla, njenge-Visine, isetyenziselwa rhoqo, ukuxhomekeke emzimbeni (abanye abantu bangabiza ngokuthi "umlutha") kwi-drop drop. Inzuzo yehla iso lihlala ixesha elincinci nangaphantsi kunye nokusetyenziswa okuqhubekayo, kwaye ubomvu nokuvuvukala kwamehlo kuya kuba nzima njengoko iyeza lithwala. Oku kubangela ukuba imfuneko yokusebenzisa iliso iyancipha amaxesha amaninzi ngemini ukugcina iso lubomvu phantsi kolawulo. Ukuxhomekeke kwimihla yokuhlaselwa kwamehlo okugqithisileyo okubizwa ngokuthi i-eyejunticestant eye drops ibizwa ngokuthi yi- conjunctivitis medicamentosa .
Le meko iba ngcono kangangeentsuku emva kokuba amaconsi anamehlo angama-decongestant aphelile, kwaye angadinga ukusetyenziswa kwezinye iindlela zokwelapha, ezifana nokuncinciza okubandayo, ukunyuka kwamehlo, kunye nokunyanga kwexesha elifutshane kunye ne-headical non-stteroidal anti-inflammatory or steroid eye ahla.
Kukho ukhetho olungcono kwi-OTC iliso lehla ukunyanga kwezilonda zamehlo, kubandakanya i-ketotifen, eyi-antihistamine yesicatshulwa kunye ne-cell-cell-stabilizing eye. I-Ketotifen ithengiswa phantsi kweempawu zeZaditor, i-Alaway, i-Eye yeClaritin, i-Eye yeZyrtec, i-Visine All Day Eye Itch Relief, kunye neenguqulelo zesi-generic .
Umthombo:
Umdlali we-SL, uRaizman MB. Conjunctivitis Medicamentosa. J Allergy Clin Immunol. 1994 Jul; 94 (1): 134-6.